Release Date: 2024-05-31

Effects of Medicinal Plants and Phytochemicals on Schizophrenia

Abdullah Dalar (Author), Muzaffer Mukemre (Author)

Release Date: 2024-05-31

Humans need medicinal plants to continue their lives in a healthy way. This need will continue in the past, present, and future. The earth can be polluted naturally or by human sources. Medicinal plants consumed by humans for various purposes can be affected by this pollution. One of the important points that people should pay [...]

Media Type
    Buy from

    Price may vary by retailers

    Work TypeBook Chapter
    Published inBrain Health and Medicinal Plants
    First Page87
    Last Page108
    DOIhttps://doi.org/10.69860/nobel.9786053359241.6
    Page Count22
    Copyright HolderNobel Tıp Kitabevleri
    Licensehttps://nobelpub.com/publish-with-us/copyright-and-licensing

    Humans need medicinal plants to continue their lives in a healthy way. This need will continue in the past, present, and future. The earth can be polluted naturally or by human sources. Medicinal plants consumed by humans for various purposes can be affected by this pollution. One of the important points that people should pay attention to is the use of medicinal plants without biological and chemical contamination. In this compiled book chapter, scientific studies on chemically and biologically contaminated medicinal plants and brain health are included. The current study is original and is expected to contribute to those interested in the subject.

    Abdullah Dalar (Author)
    Assistant Professor, Hakkari University
    https://orcid.org/0000-0002-0080-2519
    3Dr Abdullah Dalar completed his bachelor education in Biology. He earned his MSc degree in Plant Biotechnology, PhD degree in Plant Biology, and associate professorship degree in Pharmaceutical Botany and Pharmacognosy. He is self-motivated, creative researcher with 15 years of plant sciences (botanical and ecological studies), specialising in botany (including systematics, pharmaceutical botany), ethnobotany, plant conservation, plant ecology, and plant analytical studies (chemical composition and biological activities). He published several research articles indexed in WOS and contributed several book chapters regards to Plant Sciences. He has been worked as a researcher both in Türkiye (Van Yuzuncu Yil University and Mardin Artuklu University) and Australia (Western Sydney University and CSIRO Australia). He is co-founder of Hakkari University Biodiversity Research Herbarium (VPH) and Mardin Artuklu University Herbarium (MARIUM)

    Muzaffer Mukemre (Author)
    Associate Professor, Mardin Artuklu University
    https://orcid.org/0000-0001-6154-6603
    3Dr Muzaffer Mukemre earned his bachelor degree in Biology. He earned his MSc and PhD degrees in Botany. He has been worked in plant sciences including ethnobotany, taxonomy, pharmaceutial botany, and phytochemistry since 2010. He contributed plant sciences by publishing several research articles and book chapters. He has been worked in Hakkari University. He is co-founder of Hakkari University Biodiversity Research Herbarium (VPH) and researcher in Mardin Artuklu University Herbarium (MARIUM).

    • Jauhar S, Johnstone M and McKenna P.J. Schizophrenia. Lancet (London, England). 2022;399(10323): 473–486.

    • Liddle PF. The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy. Br J Psychiatry J Ment Sci. 1987;151:145–151.

    • van Os J, Rutten BP and Poulton R. Gene-Environment Interactions in Schizophrenia: Review of Epidemiological Findings and Future Directions. Schizophr Bull. 2008; 34:1066–1082.

    • Correll CU and Schooler NR. Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment. Neuropsychiatr Dis Treat. 2020; 16:519–534.

    • Sagar R, Dandona R, Gururaj G and et al. The burden of mental disorders across the states of India: the Global Burden of Disease Study 1990–2017. Lancet Psychiatry.2020; 7:148–161.

    • Selemon LD and Zecevic N. Schizophrenia: a tale of two critical periods for prefrontal cortical development. Transl Psychiatry. 2015; 5:e623–e623.

    • Bergdolt L and Dunaevsky A. Brain changes in a maternal immune activation model of neurodevelopmental brain disorders. Prog Neurobiol. 2019;175:1–19.

    • Stachowiak EK, Benson CA, Narla ST and et al. Cerebral organoids reveal early cortical maldevelopment in schizophrenia—computational anatomy and genomics, role of FGFR1. Transl Psychiatry. 2017;7:6

    • Park G-H, Noh H, Shao Z, et al. Activated microglia cause metabolic disruptions in developmental cortical interneurons that persist in interneurons from individuals with schizophrenia. Nat Neurosci. 2020;23:1352–1364.

    • Sawada T, Chater TE, Sasagawa Y, et al Developmental excitation-inhibition imbalance underlying psychoses revealed by single-cell analyses of discordant twins-derived cerebral organoids. Mol Psychiatry. 2020;25:2695–2711.

    • Page SC, Sripathy SR, Farinelli F, et al. Electrophysiological measures from human iPSC-derived neurons are associated with schizophrenia clinical status and predict individual cognitive performance. Proc Natl Acad Sci . 2022;119:e2109395119.

    • Volk DW and Lewis DA. Prenatal ontogeny as a susceptibility period for cortical GABA neuron disturbances in schizophrenia. Neuroscience. 2013;248:154–164.

    • Crawford P and Go K. V. Schizophrenia. American Family Physician. 2022;106(4): 388–396.19.

    • Zamanpoor M. Schizophrenia in a genomic era: a review from the pathogenesis, genetic and environmental etiology to diagnosis and treatment insights. Psychiatric Genetics. 2020;30(1):1–9.

    • Acar C, Kartalcı Ş. Şizofreninin Etyopatogenezinde Katekol-O-Metiltransferaz (COMT) Geninin Rolü, Psikiyatride Güncel Yaklaşımlar. 2014;6: 217-226.

    • Saleh AA, Elhelbawy NG, Azmy RM, Abdelshafy MS, Donia SS and Abd El Gayed EM. Evaluation of mRNA expression level of the ATP synthase membrane subunit c locus 1 (ATP5G1) gene in patients with schizophrenia. Biochem Biophys Rep. 2022;30:101234.

    • Nehme R, et al. The 22q11.2 region regulates presynaptic gene-products linked to schizophrenia. Nature Communications. 2022;13(1):3690.

    • Sui Y-P, Zhang X-X, Lu J-L and Sui F. New Insights into the Roles of Nogo-A in CNS Biology and Diseases. Neurochem Res. 2015;40:1767–1785.

    • Demirel ÖF, Cetin İ, Turan Ş, Sağlam T, Yıldız N and Duran A Decreased Expression of α-Synuclein, Nogo-A and UCH-L1 in Patients with Schizophrenia: A Preliminary Serum Study. Psychiatry Investig. 2017;14:344.

    • Tan E-C, Chong S-A, Wang H, Chew-Ping Lim E and Teo Y-Y. Gender-specific association of insertion/deletion polymorphisms in the nogo gene and chronic schizophrenia. Brain Res Mol Brain Res. 2005;139:212–216.

    • Ji C-J, Zeng G-Z, Han J, He W-J, Zhang Y-M and Tan N-H. Zizimauritic acids A–C, three novel nortriterpenes from Ziziphus mauritiana. Bioorg Med Chem Lett. 2012;22:6377–6380.

    • Qing L, Liu L, Zhou L, Zhang F, Gao C, Hu L and Nie S. Sex-dependent association of mineralocorticoid receptor gene (NR3C2) DNA methylation and schizophrenia. Psychiatry Res. 2020;292:113318.

    • He E, Lozano MAG, Stringer S, et al. MIR137 schizophrenia-associated locus controls synaptic function by regulating synaptogenesis, synapse maturation and synaptic transmission. Hum Mol Genet. 2018;27:1879–1891.

    • Yao Y, Guo W, Zhang S, Yu H, Yan H, Zhang H, Sanders AR, Yue W and Duan J. Cell type-specific and cross-population polygenic risk score analyses of MIR137 gene pathway in schizophrenia. iScience. 2021;24:102785.

    • Saleh AA, Elhelbawy NG, Azmy RM, Abdelshafy MS, Donia SS and Abd El Gayed EM. Evaluation of mRNA expression level of the ATP synthase membrane subunit c locus 1 (ATP5G1) gene in patients with schizophrenia. Biochem Biophys Rep. 2022;03:101234.

    • Ishiguro H, Koga M, Horiuchi Y, et al. Supportive Evidence for Reduced Expression of GNB1L in Schizophrenia. Schizophr Bull. 2010;36:756–765.

    • Vermeesch JR. The Hunt for the Chromosome 22q11.2 Deletion Syndrome Schizophrenia Genes. Biol Psychiatry. 2022;91:692–693.

    • Pvsn KK, Mitra P, Ghosh R, Gangam S, Sharma S, Nebhinani N and Sharma P. Association of the NOTCH4 gene polymorphism with schizophrenia in the Indian population. Meta Gene. 2021;29:100903.

    • Sundquist K, Frank G. et al. Urbanisation and incidence of psychosis and depression, Follow-up study of 4.4 million women and men in Sweden, Br J Psychiatry. 2004; 184: 293-298.

    • Mulvany F, O‘Callaghan E, et al. Effect of social class at birth on risk and presentation of schizophrenia: casecontrol study, BMJ. 2001;323:1398-1401.

    • Wicks S, Hjern A, et al. Social adversity in childhood and the risk of developing psychosis: A national cohort study, Am J Psychiatry. 2005;162: 1652-1657.

    • Selten JP and Cantor-Graae E. Social defeat: risk factor for schizophrenia, Br J Psychiatry. 2005;187: 101-102.

    • Wahbeh M.H and Avramopoulos D. Gene-Environment interactions in schizophrenia: A literature review. Genes. 2021;12(12):1850.

    • Zhang H, Khan A, Kushner S.A and Rzhetsky A. Dissecting schizophrenia phenotypic variation: the contribution of genetic variation, environmental exposures, and gene environment interactions. Schizophrenia (Heidelberg, Germany). 2022;8(1):51.

    • Weinberger D. R. It's dopamine and schizophrenia all over again. Biological Psychiatry. 2022;92(10):757–759.

    • Rantala M.J, Luoto S, Borráz-León J.I and Krams I. Schizophrenia: The new etiological synthesis. Neuroscience and Biobehavioral Reviews. 2022;142:104894.

    • Stone W.S, Phillips M.R, Yang L.H, Kegeles L.S, Susser E.S and Lieberman J.A. Neurodegenerative model of schizophrenia: Growing evidence to support a revisit. Schizophrenia Research. 2022;243:154–162.

    • Cuesta M.J., et al. Relapse of first-episode schizophrenia patients and neurocognitive impairment: The role of dopaminergic and anticholinergic burden. Schizophrenia Research. 2022;248:331–340.

    • Nagamine T. Role of norepinephrine in schizophrenia: An old theory applied to a new case in emergency medicine. Innovations in Clinical Neuroscience. 2020;17(7-9):8–9.

    • Yavaşçı Öztepe E and Akkaya C. Şizofrenide seratoninin rolü, Psikiyatride Güncel Yaklaşımlar, Current Approaches in Psychiatry. 201;4(2): 237-259.

    • Jenkins T, Nguyen J, Polglaze K and Bertrand P. Influence of Tryptophan and Serotonin on Mood and Cognition with a Possible Role of the Gut-Brain Axis. Nutrients. 2016;8:56.

    • Schoonover KE, Dienel SJ and Lewis DA. Prefrontal cortical alterations of glutamate and GABA neurotransmission in schizophrenia: Insights for rational biomarker development. Biomark Neuropsychiatry. 2020;3:100015.

    • Govindpani K, Beatriz Calvo-Flores Guzmán, Vinnakota C, Waldvogel H, Faull R and Kwakowsky A. Towards a Better Understanding of GABAergic Remodeling in Alzheimer’s Disease. Int J Mol Sci. 2017);18:1813.

    • Bojesen KB, Broberg BV, Fagerlund B, et al. Associations Between Cognitive Function and Levels of Glutamatergic Metabolites and Gamma-Aminobutyric Acid in Antipsychotic-Naïve Patients With Schizophrenia or Psychosis. Biol Psychiatry. 2021;89:278–287.

    • Newell KA, Zavitsanou K, Jew SK and Huang X-F. Alterations of muscarinic and GABA receptor binding in the posterior cingulate cortex in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31:225–233.

    • Park MTM, Jeon P, Khan AR, Dempster K, Chakravarty MM, Lerch JP, MacKinley M, Théberge J and Palaniyappan L. Hippocampal neuroanatomy in first episode psychosis: A putative role for glutamate and serotonin receptors. Prog Neuropsychopharmacol Biol Psychiatry. 2021;110:110297.

    • Keshavan M.S, Collin G, Guimond S, Kelly S, Prasad K.M and Lizano P. Neuroimaging in schizophrenia. Neuroimaging Clinics of North America. 2020;30(1):73–83.

    • Uyan T.T, Baltacioglu M and Hocaoglu C. Relationships between childhood trauma and dissociative, psychotic symptoms in patients with schizophrenia: a case-control study. General Psyhiatry. 2022);35(1).

    • Akbey Z.Y, Yildiz M and Gündüz N. Is there any association between childhood traumatic experiences, dissociation and psychotic symptoms in schziophrenic patients?. Psychiatry Investigation. 2019;16(5):346–354.

    • Marchi M., et al. Childhood maltreatment mediates the effect of the genetic background on psychosis risk in young adults. Translational Psychiatry. 2022;12(1):21.

    • Davis P.H. Flora of Turkey and the East Aegean Island. Vol. 8”, Edinburgh University Press, Edinburgh. 1984.

    • Gurushizde M, Mashayekhi S, Blattner Fr, Frıesen N, and Fritsch, R.M. Phylogenetic relationship of wild and cultivated species of Allium section Cepa inferred by nuclear rDNA ITS sequence analysis. Plant Systematics and Evolution. 2007;269: 259-269.

    • Dorrigiv M, Zareiyan A and Hosseinzadeh H. Onion (Allium cepa) and its Main Constituents as Antidotes or Protective Agents against Natural or Chemical Toxicities: A Comprehensive Review. Iran J Pharm Res IJPR. 2021;20:3–26.

    • Kadian R and Parle M. Evaluation of Antipsychotic Effect of Allium cepa. 2014;3:1146–1159.

    • Willborn RJ, Hall CP and Fuller MA. Recycling N-acetylcysteine: A review of evidence for adjunctive therapy in schizophrenia. Ment Health Clin. 2019;9:116–123.

    • Rossell SL, Francis PS, Galletly C, et al. N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms. BMC Psychiatry. 2016; 16:320.

    • Takayanagi T, Ishikawa T and Kitazima J. Phytochemistry 2003;63:479-84.

    • Khan R, Ahmad W, Ahmad M and Hasan A. Phytochemical and pharmacological properties of Carum carvi. Eur J Pharm Med Res. 2016;3:231–236.

    • ANajda A, Dyduch J and Brzozowski N. Veg Crops Res Bull. 2008;68:127-33.

    • Mahboubi M. Caraway as Important Medicinal Plants in Management of Diseases. Nat Prod Bioprospecting. 2019;9:1–11.

    • Udumalagala G.C, Peramune A.A.S and Prasad K. Gotu kola (Centella asiatica): nutritional properties and plausible health benefits. In Advances in Food and Nutrition Research. ed. J. Henry (Amsterdam: Elsevier). 2015;125–157.

    • Gohil K, Patel J and Gajjar A. Pharmacological review on Centella asiatica: A potential herbal cure-all. Indian J Pharm Sci. 2010;72:546.

    • Wang L, Guo T, Guo Y andXu Y. Asiaticoside produces an antidepressant‑like effect in a chronic unpredictable mild stress model of depression in mice, involving reversion of inflammation and the PKA/pCREB/BDNF signaling pathway. Mol Med Rep. 2020;22:2364–2372.

    • Chen Y, Han T, Qin L, Rui Y and Zheng H. Effect of total triterpenes from Centella asiatica on the depression behavior and concentration of amino acid in forced swimming mice. Zhong Yao Cai Zhongyaocai J Chin Med Mater. 2003;26:870–873.

    • Prachayasittikul V, Prachayasittikul S, Ruchirawat S and Prachayasittikul V. Coriander (Coriandrum sativum): A promising functional food toward the well-being. Food Res Int. 2018;105:305–323.

    • Gil A, de la Fuente EB, Lenardis AE, López Pereira M, Suárez SA, Bandoni A, van Baren C, Di Leo Lira P and Ghersa CM. Coriander Essential Oil Composition from Two Genotypes Grown in Different Environmental Conditions. J Agric Food Chem. 2002;50:2870–2877.

    • Watanabe Y, Sakurai J and Nobuo I. Effect of Coriandrum Sativum L. Leaf Extract on the Brain GABA Neurons in Mice. J Nutr Health Food Sci. 2019;7:1–7.

    • Belal A.A., Ahmed F.B and Ali L.I. Antibacterial activity of Cuminum cyminum L. oil on six types of bacteria. American Journal of BioScience. 2017;5(4), 70–73.

    • Agarwal U, Pathak D.P, Kapoor G, Bhutani R, Roper R, Gupta V and Kant R. Review on Cuminum cyminum–Nature's magical seeds. Journal of Chemical and Pharmaceutical Research. 2017;9(9), 180–187.

    • Tahir H.U, Sarfraz R.A, Ashraf A and Adil S. Chemical composition and antidiabetic activity of essential oils obtained from two spices (Syzygium aromaticum and Cuminum cyminum). International Journal of Food Properties .2016;19(10):2156–2164.

    • Dey A and De JN. Rauvolfia serpentina (L). Benth. ex Kurz.-A Review. Asian J Plant Sci. 2010;9:285–298.

    • Harisaranraj R, Suresh K, Babu SS and Achudhan VV. Phytochemical based strategies for pathogen control and antioxidant capacities of Rauvolfia serpentina Extracts, Recent Research in Science and Technology. 2009; 1:67-73.

    • Kanba S and Richelson E (eds). Herbal Medicines for Neuropsychiatric Diseases. 2013.

    • Xia M, Shahane SA, Huang R, et al. Identification of quaternary ammonium compounds as potent inhibitors of hERG potassium channels. Toxicol Appl Pharmacol. 2011;252:250–258.

    • Bunkar and Alka Rani. Therapeutic uses of Rauwolfia serpentina. Int J Adv Sci Res. 2017;2.2: 23-26.

    • Feng L, Zhai YY, Xu J, Yao WF, Cao YD, Cheng FF, et al. A review on traditional uses, phytochemistry and pharmacology of Eclipta prostrata (L.) L. J Ethnopharmacol. 2019;245:112109.

    • Latha BC, Ahalya S, Naidu PD, Mounica K and Kumar AR. Phytochemical evaluation of Andrographis paniculata, Cassia angustifolia and Eclipta alba. Indian J Res Pharm Biotechnol. 2017;5:160-3.

    • Jahan R, Al-Nahain A, Majumder S and Rahmatullah M. Ethnopharmacological Significance of Eclipta alba (L.) Hassk. (Asteraceae). Int Sch Res Not. 2014;2014:385969.

    • Yadav NK, Arya RK, Dev K, Sharma C, Hossain Z, Meena S, Arya KR, Gayen JR, Datta D and Singh RK. Alcoholic Extract of Eclipta alba Shows In Vitro Antioxidant and Anticancer Activity without Exhibiting Toxicological Effects. Oxid Med Cell Longev. 2017b;9094641.

    • Sathaye S, Shaikh M and Sancheti J. Effect of Eclipta alba on acute seizure models: a GABA A -mediated effect. Indian J Pharm Sci.2013;75:380.

    • Pandey G. Dravyaguna Vijnana. Ist ed. Varanasi: Krishnadas academy oriental Publishers & Distributors. 2001.

    • Ramachandran S. Review on Sphaeranthus indicus Linn. (Koṭṭaikkarantai). Pharmacogn Rev. 2013;7:157–169.

    • Singh N and Gilca M. Herbal medicine, science embraces tradition-a new insight into the ancient Ayurveda. Germany: Lambert Academic Publishing. 2010; p. 213-26.

    • Cassano T, Villani R, Pace L, Carbone A, Bukke VN, et al. From Cannabis sativa to cannabidiol: Promising therapeutic candidate for the treatment of neurodegenerative diseases. Front Pharmacol. 2020;11:124.

    • Chaachouay N, Benkhnigue O and Zidane L. Ethnobotanical study aimed at investigating the use of medicinal plants to treat nervous system diseases in the Rif of Morocco. J Chiropr Med. 2020.

    • Russo EB and Grotenhermen F. The Therapeutic Use of Cannabis sativa (L.) in Arabic Medicine. In: The Handbook of Cannabis Therapeutics. Routledge. 2014;pp 23-30.

    • Chaachouay N, Azeroual A, Bencharki B, Douira A and Zidane L. Cannabis sativa L.: a review on traditional uses, botany, phytochemistry, and pharmacological aspects. Traditional and Integrative Medicine. 2023;97-116.

    • Asgher M, Verma S, Khan NA, Vyas D, et al. Physiological, Biochemical and Reproductive Studies on Valeriana wallichii, a Critically Endangered Medicinal Plant of the Himalayan Region Grown under In-Situ and Ex-Situ Conditions. Plants. 2020;9:131.

    • Bhattacharya SK, Satyan KS and Ghosal S. Antioxidant activity of glycowithanolides from Withania somnifera. Indian J Exp Biol. 1997;35:236–239.

    • Vishwakarma S, Goyal R, Gupta V and Dhar KL. GABAergic effect of valeric acid from Valeriana wallichii in amelioration of ICV STZ induced dementia in rats. Rev Bras Farmacogn. 2016;26:484–489.

    • Becker A, Felgentreff F, Schröder H, Meier B and Brattström A. The anxiolytic effects of a Valerian extract is based on valerenic acid. BMC Complement Altern Med. 2014;14:267.

    • Raviraja Shetty G, Poojitha KG, Souravi K and Rajasekharan PE. Seed germination studies in Celastrus paniculatus Willd: A threated medicinal a plant. Int J Appl Agric Res. 2016;11:51–56.

    • Singh N and Gilca M. Herbal medicine, science embraces tradition-a new insight into the ancient Ayurveda. Germany: Lambert Academic Publishing; 2010; p. 213-26.

    • Sharma GN, Kaur H, Shrivastava B and Arora SC. A Revıew From Historıcal to Current-Celastrus paniculatus. Int J Pharm Pharm Sci. 2020;15–20.

    • Maurya H, Arya R, Belwal T, Rana M and Kumar A. Celastrus paniculatus. 2021;pp 425–435.

    • Gattu M, Boss KL, Terry AV and Buccafusco JJ. Reversal of Scopolamine-Induced Deficits in Navigational Memory Performance by the Seed Oil of Celastrus paniculatus. Pharmacol Biochem Behav. 1997;57:793–799.

    • Borrelli F, Borbone N, Capasso R, Montesano D, De Marino S, Aviello G, Aprea G, Masone S, and Izzo AA. Potent relaxant effect of a Celastrus paniculatus extract in the rat and human ileum. J Ethnopharmacol. 2009;122:434–438.

    • Kumar MHV, and Gupta YK. Antioxidant property of Celastrus paniculatus Willd.: a possible mechanism in enhancing cognition. Phytomedicine. 2002;9:302–311.

    • Devi P. An updated review on Shankhpushpi-As Medhya Rasayana. J Ayurvedic Herb Med. 2021;7:119–123.

    • Malik J, Karan M and Vasisht K. Nootropic, anxiolytic and CNS-depressant studies on different plant sources of shankhpushpi. Pharm Biol. 2011;49:1234–1242.

    onix_3.0::thothThoth ONIX 3.0
    onix_3.0::project_museProject MUSE ONIX 3.0
    onix_3.0::oapenOAPEN ONIX 3.0
    onix_3.0::jstorJSTOR ONIX 3.0
    onix_3.0::google_booksGoogle Books ONIX 3.0
    onix_3.0::overdriveOverDrive ONIX 3.0
    onix_2.1::ebsco_hostEBSCO Host ONIX 2.1
    csv::thothThoth CSV
    json::thothThoth JSON
    kbart::oclcOCLC KBART
    bibtex::thothThoth BibTeX
    doideposit::crossrefCrossRef DOI deposit
    onix_2.1::proquest_ebraryProQuest Ebrary ONIX 2.1
    marc21record::thothThoth MARC 21 Record
    marc21markup::thothThoth MARC 21 Markup
    marc21xml::thothThoth MARC 21 XML

    Share This Chapter!